{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:47:41Z","timestamp":1761511661343},"reference-count":29,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2002,4,4]],"date-time":"2002-04-04T00:00:00Z","timestamp":1017878400000},"content-version":"vor","delay-in-days":93,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2002,1]]},"abstract":"<jats:p><jats:bold>Objective<\/jats:bold> To identify prevalence and risk factors associated with the HIV\u2010associated lipodystrophy syndrome (HIVLD) after 3 years of antiretroviral therapy, to investigate the diagnostic value of anthropometric measures and to assess the impact of HIVLD on quality of life.<\/jats:p><jats:p><jats:bold>Design and methods<\/jats:bold> A prospective, cross\u2010sectional, multicentre, observational, cohort study was performed in 27 German teaching hospitals, nonacademic hospitals and private practices. A total of 221 HIV\u2010positive patients commencing antiretroviral therapy between July and September 1996 were studied. The main outcome measure was lipodystrophy, defined as otherwise unexplained truncal fat accumulation and\/or fat loss in face or extremities. The analysis consisted of multiple logistic regression models, receiver operating characteristics (ROC) curves for anthropometric measures and visual analogue scales for quality of life.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> The prevalence of HIVLD after 3\u2003years was 34%. The following variables were independently associated with HIV\u2010LS: stavudine use &gt;\u200a12\u2003months [odds ratio (OR) 2.1, 95% confidence interval (CI) 1.1\u20133.9], CD4 count nadir &lt;\u200a200 cells\/\u00b5L (OR 2.2, CI 1.1\u20134.6), hypertriglyceridaemia (OR 2.3, CI 1.3\u20134.2) and nonnucleoside reverse transcriptase inhibitor (NNRTI) intake &gt;\u200a12\u2003months (OR 0.2, CI 0.04\u20130.87). No cut\u2010off point was found for anthropometric indices with a sensitivity and specificity of \u2265\u20030.8. The mean visual analogue ratings for impaired quality of life, on a scale of 0\u201310, were: 5.2 (self\u2010esteem), 2.9 (social contacts), 4.2 (sexuality) and 3.5 (daily activities).<\/jats:p><jats:p><jats:bold>Conclusions<\/jats:bold> These findings suggest a multifactorial aetiology for HIVLD. Stavudine use and a CD4 count below 200 cells\/\u00b5L may be associated with an increased risk for the development of HIVLD. In contrast, NNRTI treatment may be associated with a reduced risk. Anthropometric indices were found to be insufficient as a diagnostic tool. Quality of life was severely affected by HIVLD.<\/jats:p>","DOI":"10.1046\/j.1464-2662.2001.00100.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T00:19:56Z","timestamp":1047428396000},"page":"49-55","source":"Crossref","is-referenced-by-count":48,"title":["Risk factors for the HIV\u2010associated lipodystrophy syndrome in a closed cohort of patients after 3\u2003years of antiretroviral treatment"],"prefix":"10.1111","volume":"3","author":[{"given":"S","family":"Mauss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Corzillius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Schwenk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Adam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Jaeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Knechten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Goelz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Goetzenich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the DAGN\u00c4 Lipantiretroviral therapy study group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,4,4]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199807000-00003"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199907300-00004"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)08468-2"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199912240-00002"},{"issue":"2","key":"e_1_2_6_6_2","first-page":"17","article-title":"(Please give title of presentation.)","volume":"4","author":"Kotler DP","year":"1999","journal-title":"Antiviral Ther"},{"key":"e_1_2_6_7_2","unstructured":"JaegerH WolfE HammelGet al.HAART is not hard enough: virological failure after 12 months of treatment in antiretroviral therapy\u2010naive HIV+patients.12th World AIDS Conference.Geneva Switzerland July 2000[Abstract32319]."},{"key":"e_1_2_6_8_2","first-page":"929","article-title":"Use and interpretation of anthropometric indicators of nutritional status","volume":"643","author":"World Health Organization Working Group.","year":"1986","journal-title":"Bull WHO"},{"key":"e_1_2_6_9_2","unstructured":"The SAS System.Cary NC SAS Institute Inc1999."},{"issue":"2","key":"e_1_2_6_10_2","first-page":"47","article-title":"Lipodystrophic syndromes in a cohort of HIV\u20101\u2010infected patients receiving HA antiretroviral therapy with a protease inhibitor","volume":"4","author":"Viard JP","year":"1999","journal-title":"Antiviral Ther"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200007070-00002"},{"key":"e_1_2_6_12_2","unstructured":"BernasconiE CarotaA MagentaLet al.Metabolic changes in HIV\u2010infected patients treated with protease inhibitors.12th World AIDS Conference.Geneva Switzerland June\u2013July 1998[Abstract12375]."},{"key":"e_1_2_6_13_2","unstructured":"BonnetE CuzinL SaillerMet al.Associated lipodystrophy metabolic disorders due to protease inhibitor containing regimen.12th World AIDS Conference.Geneva Switzerland June\u2013July 1998[Abstract12299]."},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199806000-00001"},{"key":"e_1_2_6_15_2","unstructured":"El\u2010SadrWM CollinsG RaghavanSet al.Prevalence of metabolic complications in a large diverse cohort of HIV\u2010infected persons.7th Conference on Retroviruses and Opportunistic Infections.San Francisco CA January\u2013February 2000[Abstract13]."},{"key":"e_1_2_6_16_2","unstructured":"MolinaJM AngeliniE CotteLet al.Prevalence of lipodystrophy in the long\u2010term follow\u2010up of a clinical trial comparing various combinations of nucleoside reverse transcriptase inhibitors ALBI trial (ANRS 070).7th Conference on Retroviruses and Opportunistic Infections.San Francisco CA January\u2013February 2000[Abstract19]."},{"key":"e_1_2_6_17_2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00002030-200001070-00005","article-title":"Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study","volume":"14","author":"Saint\u2010Marc T","year":"2000","journal-title":"AIDS"},{"key":"e_1_2_6_18_2","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/00002030-199909100-00009","article-title":"A syndrome of peripheral fat wasting (lipodystropy) in patients receiving long\u2010term nucleoside analogue therapy","volume":"13","author":"Saint\u2010Marc T","year":"1999","journal-title":"AIDS"},{"key":"e_1_2_6_19_2","unstructured":"PoloR VerdejoJ Gonzales\u2010MunozMet al.Lipodystrophy related to NRT inhibitors in HAART.39th Interscience Conference on Antimicrobial Agents and Chemotherapy.San Francisco CA October 1999[Abstract1302]."},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)06102-4"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200002180-00001"},{"key":"e_1_2_6_22_2","unstructured":"TashimaK StrykerR SkiestDet al.Lack of clinical lipodystrophy in patients receiving efavirenz+ NRTIs in study 006.39th Interscience Conference on Antimicrobial Agents and Chemotherapy.San Francisco CA October 1999[Abstract1304]."},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91058-G"},{"key":"e_1_2_6_24_2","first-page":"518","article-title":"Endocrine and metabolic disturbance in human immunodeficieny virus infection and the acquired immune deficiency syndrome","volume":"17","author":"Sellmeyer DE","year":"1996","journal-title":"Endocr Rev"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.3109\/08830189809043015"},{"issue":"2","key":"e_1_2_6_26_2","first-page":"41","article-title":"Lipodystrophy, glucose and lipid metabolism dysfunctions. Aquitaine Cohort, 1999","volume":"4","author":"Thi\u00e9baut R","year":"1999","journal-title":"Antiviral Ther"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199907090-00001"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200001070-00006"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)03391-1"},{"key":"e_1_2_6_30_2","unstructured":"KotlerDP RosenbaumKB WangJ PiersonRNJr.Alterations in body fat distribution in HIV\u2010infected men and women.12th World AIDS Conference.Geneva Switzerland June\u2013July 1998[Abstract32173]."}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1464-2662.2001.00100.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1464-2662.2001.00100.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T05:28:20Z","timestamp":1697520500000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1464-2662.2001.00100.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["10.1046\/j.1464-2662.2001.00100.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1464-2662.2001.00100.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"type":"print","value":"1464-2662"},{"type":"electronic","value":"1468-1293"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}